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Abstract
Growth arrest-specific 2-like protein 3 (Gas2l3) was recently identified as an Actin/Tubulin cross-linker protein that regulates
cytokinesis. Using cell-free systems from both frog eggs and human cells, we show that the Gas2l3 protein is targeted for
ubiquitin-mediated proteolysis by the APC/C
Cdh1 complex, but not by the APC/C
Cdc20 complex, and is phosphorylated by
Cdk1 in mitosis. Moreover, late in cytokinesis, Gas2l3 is exclusively localized to the constriction sites, which are the
narrowest parts of the intercellular bridge connecting the two daughter cells. Overexpression of Gas2l3 specifically
interferes with cell abscission, which is the final stage of cell division, when the cutting of the intercellular bridge at the
constriction sites occurs. We therefore suggest that Gas2l3 is part of the cellular mechanism that terminates cell division.
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Introduction
Dividing cells ensure the symmetric distribution of their genetic
material by multiple modes of regulation. A series of phosphor-
ylation events, as well as strictly regulated proteolysis, mediated
mainly by the Anaphase-Promoting Complex/Cyclosome (APC/
C) E3 ubiquitin ligase, coordinate the spindle assembly checkpoint
removal and sister-chromatid separation, and the metaphase-to-
anaphase transition [1,2]. In parallel, cytokinesis, which starts with
the formation of the cleavage furrow, halves the cell’s cytoplasm
and eventually two daughter cells are formed [3]. APC/C in
complex with Cdh1 targets key cytokinesis regulators, such as the
mitotic kinases Plk1 and Aurora B, and Anillin, for proteasome-
dependent degradation in late telophase and throughout the G1
phase of the cell cycle [4,5]. This proteolysis has been shown to be
important for progression through cytokinesis and mitotic exit
[4,6].
The final step of the cell cycle is cell abscission; that is, the
cutting of the thin microtubule and membrane bridge connecting
the two daughter cells at specific locations on both sides of the
midbody, called the constriction sites (also known as the
‘‘abscission zones’’) [7]. At these sites, the microtubule bundles
are at their narrowest [8,9,10]. The molecular mechanisms
underlying cell abscission and the way in which abscission is
coordinated with the cell cycle, are still mostly unclear; neverthe-
less, it has been shown recently that components of the ESCRT
membrane transport system, in particular the ESCRT-III complex
[8,9] and the microtubule-severing machinery [7,11], are recruited
to the constriction sites to trigger the microtubule breakage and
membrane scission that end the cell division process. In addition,
recent findings suggest that orderly abscission is, at least in part,
mediated by the Plk1-regulated recruitment of abscission factors
[6].
Partitioning the cell content requires components of the Actin
filament network, in particular those of the contractile ring, as well
as components of the microtubule network and of the cell
membrane [3]. Coordinating these components together enables
the synchronization of chromosome segregation with cleavage
furrow ingression and the actual act of cell division, but it is also
essential for a variety of fundamental cellular activities, such as cell
polarization and migration. A series of cross-linker proteins, in
particular spectraplakins, can directly interact with Actin filaments
and microtubules, as well as with intermediate filaments, and
integrate them into one cytoskeleton network that can also
communicate with other cellular structures, such as membranes
[12].
PLOS ONE | www.plosone.org 1 February 2013 | Volume 8 | Issue 2 | e57532Growth arrest-specific 2-like (Gas2l) proteins comprise a
subfamily of spectraplakin-like cross-linking factors that bind Actin
filaments and microtubules through their Calponin homology
(CH) and GAS2-related (GAR) domains, and possibly through
other binding domains [13,14,15]. The family includes three
proteins: Gas2l1, Gas2l2, and Gas2l3, all named after their GAR
signature motifs. The expression of Gas2 itself was identified to be
specifically elevated during cell growth arrest [16], and has been
shown to inhibit cell division and activate apoptosis in vertebrate
embryos [15,17,18].
It was recently reported that GAS2L3 transcription is cell cycle-
regulated via the DREAM/E2F protein complex. Furthermore,
the results of RNAi experiments have suggested a role for Gas2l3
in cytokinesis [19]. Here we show that Gas2l3 is a novel
constriction site-associated protein and an APC/C
Cdh1 target
whose overexpression interferes with cell abscission.
Results
Gas2l3 is a Cell Cycle-regulated Protein and a Novel
Substrate of the APC/C
Cdh1 Complex
We found the gene encoding for growth arrest-specific 2-like
protein 3 (Gas2l3) to be a putative cell cycle regulator in vivo using
gene expression analysis of proliferating vs. resting murine B cells
[20]. Gas2l3 belongs to the Gas2 subfamily of microtubule/Actin
cross-linking factor proteins [13,14,15]. Of the Gas2 family, the
GAS2, GAS2L1, and GAS2L3 genes were analyzed in the
GSE4142 dataset [20] and out of the three, only GAS2L3, much
like the mitotic cyclin A2 (CCNA2), is highly expressed in the two
proliferating B-cell types (germinal center [GC] and plasmablasts)
compared to the two resting B-cell types (naı ¨ve and memory). In
comparison, GAS2L1 is highly expressed only in GC cells, and the
expression of GAS2 is roughly equal in the four B-cell types
(Figure 1A). Expression analysis of GAS2L3 in synchronous HeLa
S3 (S3) cells has also shown that this gene is periodically expressed
in proliferating cells in a manner similar to that of the mitotic
Cyclin A2 (Figure 1B).
The molecular weight prediction (by sequence) of human
Gas2l3 is 75.2 kDa. We were unable to detect the endogenous
Gas2l3 by Western blotting or immunoprecipitation in numerous
human cell lines using commercial antibodies. We therefore
generated a polyclonal rabbit hGas2l3 antibody and tested its
specificity in HEK293T (293) cells overexpressing human Gas2l3
or its EGFP-tagged version. With these antibodies, we specifically
detected exogenously expressed Gas2l3 as well as the EGFP-
tagged form of the protein (with a calculated molecular weight of
104.5 kDa) (Figure 1C). Nevertheless, despite our efforts, we were
unable to conclusively detect by Western blotting the endogenous
protein in 293 cells (Figure 1C) or in other human cell lines using
our antibody.
Cell cycle proteins such as the mitotic cyclins are often tightly
regulated by the ubiquitin-proteasome system, which times their
destruction at specific points along the cell cycle. Treating 293 cells
overexpressing Gas2l3 with the proteasome inhibitor MG132
resulted in a significant accumulation of the protein (Figure 1D,
left). In order to test whether proteasome-dependent degradation
of Gas2l3 takes place in G1 as it does for the mitotic cyclins,
radiolabeled (
35S) in vitro translated/transcribed (IVT) Gas2l3
product was incubated in cell extracts made from S3 cells
synchronized in G1 [21]. Gas2l3 was almost undetectable after
80 min of incubation in control extracts, but remained stable in
extracts supplemented with MG132 (Figure 1D, right), indicating
that Gas2l3 undergoes proteasome-dependent degradation in G1.
We next tested whether the degradation of Gas2l3 in G1
extracts is mediated by the APC/C, which targets the mitotic
cyclins and numerous other key cell cycle proteins for destruction
[1]. To this end, a radiolabeled Gas2l3 IVT product was
incubated in G1-phase cell extracts supplemented with either the
C-terminal region of the APC/C specific inhibitor Emi1 or with
an excess of Securin, a specific competitive inhibitor, both of
which block APC/C-dependent degradation [21,22]. As positive
controls, we showed that radiolabeled Geminin and Tome-1, both
known substrates of the APC/C [23,24], are effectively degraded
in these extracts but not in the presence of Emi1 or Securin.
Results shown in Figure 1E demonstrate that Gas2l3 is degraded
in G1 extracts only in the absence of Emi1 or Securin, indicating
that Gas2l3 is a target of the APC/C.
APC/C substrates typically carry one or both of two recognition
motifs known as the destruction box (D-box) (consensus sequence:
RXXL) and the KEN-box. Gas2l3 carries four RXXL motifs, and
we have generated four mutant derivates of Gas2l3 (D-box Mutant
[DM] 1–4), in which the Arg and Leu at positions 1 and 4 of each
of the four putative D-box sequences were substituted with Gly
and Val, respectively (Figure 1F, left). Mutations at Arg610 and
Leu613 (the Gas2l3-DM4 derivate) completely blocked Gas2l3
degradation in G1 extracts, while mutations at all other sites had
either no (Gas2l3-DM1 and Gas2l3-DM3) or a limited (Gas2l3-
DM2) effect (Figure 1F, right). We next tested the stability of
Gas2l3 and Gas2l3-DM4 in 293 cells overexpressing Cdh1, which
mediates the ubiquitination of nearly all known APC/C substrates
[1]. Western blot analysis with anti-hGas2l3 rabbit serum revealed
that exogenously expressed Gas2l3, but not Gas2l3-DM4, is highly
sensitive to elevated levels of Cdh1 in cells (Figure 1G). We can
therefore conclude that Gas2l3 is a bona fide D-box–dependent
APC/C substrate.
The degradation of D-box–containing proteins is mediated
either by Cdc20 (at anaphase and early telophase) and Cdh1 (at
late telophase and throughout G1), or exclusively by Cdh1. This
specific timing of protein degradation is a key regulatory
mechanism that ensures the correct progression of cells through
mitosis and G1 [1,25]. We used the Xenopus laevis egg-extract
system to differentiate which of the APC/C complexes drives
Gas2l3 degradation: APC/C
Cdc20 is highly active in egg extracts
driven into mitosis by an excess of non-degradable Cyclin B1 [26];
meanwhile, APC/C
Cdh1 activity, not being present in pre-mid-
blastula transition (MBT) embryos, can be restored in interphase
egg extracts by adding recombinant Cdh1 [24,27].
The degradation of Gas2l3 was assayed in both mitotic and
interphase frog egg extracts. Geminin, an APC/C
Cdc20 and APC/
C
Cdh1 substrate, and Tome-1, an APC/C
Cdh1 substrate, were used
as controls for the extracts’ activities and specificities. Geminin
disappeared quickly in mitotic extracts unlike Tome-1, which
remained stable and shifted to a high-mobility form, as previously
reported (Figure 2A, left panels) [24]. Geminin is not degraded nor
is Tome-1 modified in interphase extracts, thus excluding the
possibility of contamination by mitotic APC/C
Cdc20-active
extracts (Figure 2A, right panels). Gas2l3 was stable in mitotic
extracts (Figure 2A, left panels), but degraded in a D-box–
dependent manner in interphase extracts supplemented with
recombinant Cdh1 (Figure 2A, right panels).
Geminin, Tome-1, and Gas2l3 degradation was also examined
in somatic cell extracts with high APC/C
Cdc20 activity made from
293 cells arrested in late mitosis by the overexpression of D-box
mutant full-length Cyclin B1 [25]. This extract system, described
here for the first time, can be referred to as the human equivalent
of the X. laevis mitotic extracts, in which APC/C
Cdc20 is highly
active (for further details, see the Materials and Methods section).
APC/C Targets Gas2l3, a Constriction Site Protein
PLOS ONE | www.plosone.org 2 February 2013 | Volume 8 | Issue 2 | e57532Figure 1. Gas2l3 is a cell cycle-regulated protein whose degradation is mediated by the APC/C. (A) Normalized expression levels of the
mouse genes GAS2, GAS2L1, GAS2L3, and CCNA2 in naı ¨ve, plasmablast, germinal center (GC), and memory-B cells. Raw data were taken from the GEO
database GSE4142. (B) Real-time PCR analysis of human GAS2L3 and CCNA2 expression throughout the cell cycle of HeLa S3 (S3) cells, normalized to
ACTB RNA levels at time point 0. Cells were double-thymidine blocked, released, and harvested for RNA extraction every 2 hrs for 24 hrs. Cell cycle
progression of the synchronous populations (measured by propidium-iodide (PI) staining followed by FACS analysis) is depicted under the plot. (C)
HEK293 (293) cells overexpressing human Gas2l3 or Gas2l3-EGFP were harvested for Western blot analysis with custom-made polyclonal hGas2l3
antibodies (serum). A cross-reactive band is noted (asterisk) in the transfected and untransfected (UT) cells. Forty mg extracts made from transfected
cells and 120 mg extracts made from untransfected cells were assayed. (D) Left: 293 cells were transfected with the Gas2l3 expression vector. After
24 hrs, cells were treated with MG132 for 5 hrs and subjected to Western blotting with Gas2l3 (serum) and Actin antibodies (loading control). Right:
Human Gas2l3 was expressed in rabbit reticulocytes supplemented with radiolabeled (
35S) methionine. In vitro transcribed/translated (IVT) Gas2l3
product was incubated in G1 extracts of S3 cells in the presence of MG132 or DMSO (control). Time-dependent degradation was assayed by SDS-
PAGE and autoradiography. (E)
35S-labeled hGeminin, hTome-1, and hGas2l3 IVT products were incubated in G1-phase S3 cell extracts supplemented
with either buffer, the C-terminus of hEmi1, or hSecurin. Time-dependent degradation was assayed by SDS-PAGE and autoradiography. (F) Left: The
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PLOS ONE | www.plosone.org 3 February 2013 | Volume 8 | Issue 2 | e57532Geminin is quickly degraded in this system but is stabilized in the
presence of Ubch10
DN – the dominant negative derivate of the E2
enzyme UbcH10– thus excluding the presence of any non-specific
proteolytic activity in these extracts (Figure 2B). In contrast,
Tome-1 remains stable irrespective of the presence of UbcH10
DN
(Figure 2B), and shifts to the high-mobility form, as in X. laevis
mitotic extracts (Figure 2A). Like Tome-1, Gas2l3 is stable in late
mitosis extracts (Figure 2B) but is degraded in G1-phase cell
extracts containing the active APC/C
Cdh1 complex (Figure 1E).
Additionally, the high-mobility forms of Gas2l3, as well as those of
the two known Cdk1 targets Tome-1 and Securin [24,28], are
undetectable in the presence of the Cdk1 inhibitors RO-3306 and
roscovitine (Figure 3A), suggesting that Gas2l3 is a target of Cdk1.
Mass-spec analysis of gel-extracted proteins from 293 cells
overexpressing Myc-tagged Gas2l3 and either non-degradable
Cyclin B1 (late mitosis [M]) or empty vector (unsynchronized
putative D-boxes of human Gas2l3 are depicted. Right: Arg at position 1 and Leu at position 4 of each putative D-box were substituted with Gly and
Val, respectively. The degradation of the four D-box mutants (DM1–DM4) was assayed as described in (D). (G) 293 cells were cotransfected with Cdh1
(+) or empty vector (-), and with either Gas2l3 or its mutant derivate Gas2l3-DM4, at a 4:1 ratio, respectively. After 30 hrs cells were harvested for
Western blotting with anti-hGas2l3 (serum) and anti-Tubulin (control).
doi:10.1371/journal.pone.0057532.g001
Figure 2. Gas2l3 degradation is mediated by APC/C
Cdh1, but not by APC/C
Cdc20. (A) Incubation of IVT-generated Tome-1, Geminin, Gas2l3,
and Gas2l3-DM4 in X. laevis interphase egg extracts (right) supplemented with recombinant Cdh1 (+) or buffer (-), or in extracts driven into mitosis
(left) by preincubation with recombinant non-degradable Cyclin B1 protein [D90 (23)]. (B) APC/C
Cdc20-active extracts were made from 293 cells
arrested in late mitosis by overexpression of His-tagged non-degradable hCyclin B1. Degradation of IVT-generated positive (Geminin) and negative
(Tome-1) controls and of Gas2l3 was assayed in extracts supplemented with mock (-) or dominant negative UbcH10 (Ubch10
DN). Time-dependent
degradation was assayed by SDS-PAGE and autoradiography.
doi:10.1371/journal.pone.0057532.g002
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PLOS ONE | www.plosone.org 4 February 2013 | Volume 8 | Issue 2 | e57532[US]), revealed two Cdk1 sites in Gas2l3. Moreover, these two
peptides were found to be phosphorylated only in the late mitotic
extracts (Figure 3B). Taken together, these results show that
Gas2l3 is targeted for degradation by the APC/C
Cdh1 complex,
but not by the APC/C
Cdc20 complex, and is a Cdk1 substrate.
Gas2l3 is a Constriction Site-associated Protein
During interphase, Gas2l3 colocalizes with both microtubules
and Actin filaments, as predicted by its CH and GAR domains
and recently confirmed [13]. As cells progress through telophase,
Gas2l3 becomes exclusively associated with the midzone micro-
tubules, and later with the midbody [19].
The final stage of cytokinesis is cell abscission – the cutting of
the membrane bridge connecting the two daughter cells from both
sides of the stembody [3]. The constriction sites (schematically
depicted in Figure 4A) are present at the narrowest part of the
microtubule bridge (for a brief explanation, see Ref [7]), and can
also be inferred by the less intense immunofluorescence (IF) signal
of Tubulin, which most likely is the result of the dense (and thus,
less accessible for IF labeling) microtubules at these sites [7,8,9,10].
In addition, the recruitment of the ESCRT-III complex, in
particular CHMP4b and Spastin, to the constriction sites, is
considered a prerequisite for cell abscission [7,8,9].
EGFP-tagged Gas2l3 (Figure 4B), as well as the endogenous
protein (Figure 4C), are flanked by Aurora B at the midbody (see
Figures S1 and S2 for supporting information regarding Gas2l3
localization and antibody specificity). Importantly, the Gas2l3
signal peaks exactly at the constriction sites, where both the
Tubulin and the Aurora B fluorescent signals are less intense (see
linescans in Figures 4B and 4C) and the microtubule bridge is at its
narrowest point (Figure 4D). Moreover, Gas2l3 colocalizes with
both CHMP4b and Spastin at the constriction sites (Figure 4E).
Endogenous Gas2l3 and both N- and C-terminal EGFP-tagged
Gas2l3 are indistinguishably localized to the constriction sites
(Figures 4 and S3A). Furthermore, the D-box has no effect on
Gas2l3 localization to the constriction sites (Figure S3B) or any
other site throughout the cell cycle (data not shown). We therefore
Figure 3. Gas2l3 is a Cdk1 target. (A) The phosphorylation of Securin, Tome-1 (positive controls), and Gas2l3 was assayed in 293 late mitotic
extracts [see (B) for details] in the presence of the Cdk1 inhibitors RO-3306 or roscovitine (+), or DMSO (-). Because Securin is naturally degraded in
this extract system, Securin phosphorylation was assayed in the presence of MG132. (B) 293 cells were cotransfected with Myc-tagged Gas2l3 and
either non-degradable Cyclin B1 or empty vector to generate asynchronous (US) and late mitotic (late M) cell populations overexpressing Gas2l3. The
cells were harvested after 24 hrs for Western blotting (with the depicted antibodies) and analysis by liquid chromatography-mass spectrometry (LC-
MS/MS). The samples were separated by SDS-PAGE and the area of interest, as determined by Western blotting, was excised for in-gel digestion
following established protocols. The resulting peptide mixture was analyzed using a Q Exactive mass spectrometer (Thermo Scientific) equipped with
a nanoflow UPLC system (Eksigent). The LC-MS data were searched against a human protein sequence database (Uniprot/Swissprot, canonical and
isoform sequence data) using ProteinPilot (v4.5, AB Sciex), allowing for biological modifications/phosphorylation emphasis. Only peptide-spectrum
matches above a 1% FDR cut-off were considered for further analysis. The amino acid sequence of two phosphopeptides is depicted.
doi:10.1371/journal.pone.0057532.g003
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PLOS ONE | www.plosone.org 5 February 2013 | Volume 8 | Issue 2 | e57532Figure 4. Gas2l3 is localized to the constriction sites. (A) Schematic representation of the midbody. (B) HeLa cells expressing EGFP-tagged
Gas2l3 were fixed, immunolabeled with either anti-Aurora B or anti-Tubulin, and stained with DAPI. The localization of proteins to the midbody was
determined using linescans (stembody and constriction sites are labeled by red and white arrows, respectively). (C) HeLa cells were fixed and
immunolabeled with anti-hGas2l3 (serum), and with either anti-Aurora B or anti-Tubulin. Linescans for cells 1 and 2 are plotted. (D) HeLa cells were
fixed and immunolabeled with anti-hGas2l3 (serum). The immunofluorescent intensity of the endogenous Gas2l3 at six points across one side of the
midbody were measured relative to the width of the intercellular microtubule bridge at these locations (see average and standard error values for
N=5 at the plot, and the scheme underneath). Width and intensity values were normalized to the intercellular bridge width and Gas2l3 intensity at
the constriction sites. (E) HeLa cells expressing FLAG-tagged human CHMP4b (top panels), Gas2l3-EGFP and FLAG-CHMP4b (mid panels), or Gas2l3-
EGFP and Myc-tagged human Spastin (bottom panels), were fixed and immunolabeled with anti-hGas2l3 (serum [top panels]), anti-FLAG (mid
panels), or anti-Myc (bottom panels). Linescans are depicted. We used a Zeiss AxioImager and 100X oil lens for imaging, and ImageJ software for
image analysis.
doi:10.1371/journal.pone.0057532.g004
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PLOS ONE | www.plosone.org 6 February 2013 | Volume 8 | Issue 2 | e57532conclude that Gas2l3 is a new member of the very small group of
constriction site-associated proteins.
Overexpression of Gas2l3 Interferes with Cell Abscission
Gas2l3 degradation requires the APC/C
Cdh1 and, thus, is
unlikely to regulate the metaphase-to-anaphase transition because
Cdh1 mediates protein degradation only after cytokinesis has
commenced [1]. It is therefore easy to speculate that Gas2l3 is
required to coordinate cytokinesis, as was recently suggested based
on RNAi experiments [19], but must be degraded as part of a
mechanism that terminates cell division, as was suggested for other
cytokinesis regulators that are targeted for destruction by the
APC/C
Cdh1 (e.g., Plk1 and Aurora B [4,6]).
In a population of cells growing exponentially, the proportion of
daughter cells still attached by a midbody is expected to be low
due to the relatively short duration of cytokinesis and cell division
with respect to the total length of the mammalian cell cycle. In
fixed HeLa cells, we measured this proportion to be 3.305% in
cells transfected with EGFP as control (Figure 5A). This
proportion increased over fourfold in cells overexpressing EGFP-
tagged Gas2l3. Moreover, this notable phenotype was even more
prevalent for the D-box mutant Gas2l3, where nearly 20% of the
transfected cells were attached by an intercellular bridge (detected
by the midbody marker MKLP1 [10]). This is equivalent to .6
times the frequency found in the EGFP-transfected cells, and is
significantly more frequent (by 34%) in comparison to cells
expressing the w.t. Gas2l3-EGFP (p-value [Gas2l3 w.t. vs.
DM4]=1.9533610
25, calculated by the Fisher’s exact test)
(Figure 5A). Interestingly, nearly all daughter-cell pairs overex-
pressing Gas2l3 were in interphase (evident by their decondensed
chromatin, their shape, and the presence of nuclei), fully adherent,
and although they were separated from each other – some by a
large distance of over 50 microns (e.g., cell 6 DM4 in Figure 5B) –
they were still attached by a thin, long, and often abnormally
structured microtubule bridge. For example, in cell 5 DM4
(Figure 5B), a midbody remnant, marked by the midbody ring
protein MKLP1, is absorbed in one of the two daughter cells (see
the white arrow and the matching magnified images), yet a thin
and aberrant Tubulin bridge connecting these cells is present.
These results suggest that high levels of Gas2l3 appear to permit
cytokinesis but prevent cell abscission.
Discussion
Gas2l3 is a Cell Cycle-regulated Protein
The expression pattern of Gas2l3 in proliferating cells in vivo
(Figure 1A) and in culture cells (Figure 1B, and [19]) resembles
that of the mitotic cyclins. At the protein level, Gas2l3 interacts
with the cell cycle by at least three modes. The first is proteasome-
dependent protein degradation: Gas2l3 is a target of the APC/
C
Cdh1 complex and is degraded by the proteasome in a D-box–
dependent manner (Figures 1 and 2). This regulation ensures that
Gas2l3 levels will drop late in mitosis, when cytokinesis is in an
advanced state, and will remain low until the G1/S transition.
Recent RNAi experiments suggest that Gas2l3 is dispensable for
mitotic-spindle formation and for metaphase and anaphase, but is
required for telophase and cytokinesis [19]. The need for Gas2l3
in late mitosis is in perfect agreement with its resistance to APC/
C
Cdc20-dependent degradation (Figure 2). This also suggests that
Gas2l3 degradation is unlikely to regulate sister-chromatid
separation and metaphase-to-anaphase transition.
The second mode is phosphorylation: Gas2l3 is mobility-shifted
in mitotic extracts by Cdk1-mediated phosphorylation (Figure 3).
It is easy to speculate that this phosphorylation, perhaps in concert
with the Plk1 and Aurora kinases, is an additional mode of
regulation of Gas2l3 function and localization, as shown for other
cytokinesis regulators. We detect Gas2l3 by SDS-PAGE slightly
higher than the 75 kDa marker (Figure 1C), in agreement with the
protein’s predicted molecular weight (75.2 kDa). In their recent
publication, Wolter et al. conclusively detected Gas2l3 at 95 kDa
[19]. Our findings indicate that Gas2l3 can be shifted to a higher
mobility form by phosphorylation, although not by the equivalent
of 20 kDa (Figure S4). Whether the 95 kDa band reported by
Wolter et al. [19] is a modified form of Gas2l3 is, therefore,
unclear.
The third mode is protein localization: Gas2l3 localization in
proliferating cells is dynamic. During interphase, the protein is
associated with both the microtubule and the Actin-filament
networks. During cell division, Gas2l3 shifts from the mitotic
spindles to the midzone microtubules, and later to the midbody. At
these sites, structural, regulatory, and motor proteins are
assembled to regulate cytokinesis progression and mitotic exit [10].
Gas2l3 is a Constriction Site-associated Protein whose
Misregulation Interferes with Cell Abscission
Cell abscission occurs at the constriction sites. Some of the
proteins involved include Spastin and the ESCRT-III complex
subunit CHMP4b, which regulate microtubule severing and
membrane scission, respectively [7,8,9]. We show that Gas2l3 is
specifically localized to the narrowest part of the microtubule
bundles in the intercellular bridge concomitantly with CHAM4b
and Spastin. As such, Gas2l3 is a novel constriction site-associated
protein (Figure 4).
Cells overexpressing Gas2l3 undergo cytokinesis and exit
mitosis: the daughter cells decondense their chromatin, reform
nuclei, reattach to the surface, and advance through the cell cycle,
yet they remain connected by a thin and often abnormally long
and misshaped intercellular bridge. This phenotype is significantly
more prominent in cells expressing the D-box mutant derivate of
Gas2l3, suggesting that it is not simply the result of saturating the
APC/C
Cdh1 machinery by the overexpressed Gas2l3, but is
specific to the activity of Gas2l3. More importantly, in view of
these findings, it is now easy to speculate that timely expression of
Gas2l3, as controlled by APC/C
Cdh1-mediated proteolysis, plays a
role in finalizing cell division (Figure 5).
Abnormal intercellular bridges are also formed in response to
Securin overexpression or stabilization (Securin, in concert with
Separin, regulates sister-chromatid separation [29]). In this
particular case, thin chromatin bridges connecting the two
daughter cells are formed [30]. We were unable to detect
chromatin in the intercellular bridges of Gas2l3 overexpressing
cells, suggesting that the sister chromatids underwent full
separation. It therefore seems that while the abnormal bridges
induced by non-degradable Securin are an epiphenomenon of
incomplete chromatid separation, high levels of Gas2l3 interfere
specifically with cell abscission. Morphologically, however, the
outcomes appear misleadingly similar.
The suggested role of Gas2l3 in cell abscission is in perfect
agreement with the protein’s localization at the constriction sites,
and it is plausible that Gas2l3 acts in concert with other
constriction site-associated proteins, regulating microtubule sever-
ing and membrane scission. At present, we do not understand how
Gas2l3 regulates cell abscission. There is no indication that the
downregulation of Gas2l3 interferes specifically with cell abscission
[19]; however, high levels of Gas2l3, and more so of its stable
variant, certainly do so (Figure 5). In view of this observation, it is
easy to speculate that Gas2l3 inhibits cell abscission, and that its
destruction is required for properly terminating the cell division
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and Barr’s elegant work which suggests that Plk1 negatively
regulates cell abscission, and that its degradation by the APC/
C
Cdh1 targets Cep55 to the midbody and promotes cell abscission
[6].
Alternatively, but not in a mutually exclusive manner, one can
speculate that a protein that binds Actin and/or Tubulin may itself
act as a scaffold protein [31], as shown for the adenomatous
polyposis coli (APC) protein [32] and for spectraplakins [33].
Scaffold proteins are tethering agents with a biphasic mode of
action (the ‘‘biphasic effect’’); that is, too-low or too-high protein
concentrations are suboptimal but an optimal outcome is achieved
at an intermediate concentration (see reference [31] for an
excellent explanation of the biphasic effect). Although the crystal
structure of Gas2l3 is still a work in progress, one can speculate
that this protein, be its role regulatory or structural, may function
as a tethering agent that brings proteins, as well as membrane
components, to the constriction sites to induce cell abscission. In
such a scenario, the level of Gas2l3 at the mitotic exit must be
perfectly balanced for cell abscission to be properly executed.
Materials and Methods
Plasmids
Human GAS2l3 cloned into the pCMV-SPORT6 vector was
purchased from the ATCC (ATCC clone # 7192847). In all D-
box mutant (DM) variants, Arg 1 and Leu 4 of each D-box were
substituted with Gly and Val using QuikChange site-directed
mutagenesis (Stratagene). Emi1 C-terminus (amino acids 299–447)
cloned into pGEX-4T-3 was a gift from Dr. Tao Wu [22], and
pCS2-hCdh1 was a gift from Dr. Andrea Ballabeni. The cloning
of pET28-UbcH10, pET28-UbcH10
C114S (UbcH10
DN), pET28-
hSecurin, pCS2-hSecurin, and pCS2-hGeminin, was described in
[21]; pCS2-Tome-1 was described in [24]. The expression vectors
FLAG-tagged human CHAM4b and Myc-tagged human Spastin
were kindly provided by Dr. Natalie Elia.
The sequences of human GAS2L3 and its D-box derivate
GAS2L3-DM4 were amplified with primers flanked by XhoI
(forward) and BamHI (reverse) sites and cloned into EGFP-N1 and
EGFP-C1 vectors (Clontech). The EGFP-fused GAS2L3 and
GAS2L3-DM4 constructs were amplified with primers flanked by
Fse1 (forward) and Asc1 (reverse) sites and cloned into the pCS2
vector for in vitro and in vivo expression. In addition, GAS2L3 and
Figure 5. High levels of Gas2l3 interfere with cell abscission. (A) HeLa cells were transfected with vectors expressing Gas2l3-EGFP, Gas2l3-
DM4-EGFP, or EGFP (control). Thirty-two hrs post-transfection, cells were fixed and immunolabeled, as described in Figure 4C. The slides were
scanned using a Zeiss AxioImager upright microscope and 100X oil lens for imaging. Transfected (green) cells were counted in order to detect 500
positive daughter cell pairs connected by a midbody (positives). The proportion of attached daughter cells equals 500/N, where N=the number of
transfected cells (N - 500= the number of negatives). (B) HeLa cells were transfected with vectors expressing EGFP-tagged Gas2l3 (wt) or Gas2l3-DM4.
Thirty-two hours post-transfection, cells were fixed, immunolabeled with anti-MKLP1 (stembody marker) and anti-Tubulin, and stained with DAPI. We
used a Zeiss AxioImager Z1 upright microscope and 100X oil lens for imaging.
doi:10.1371/journal.pone.0057532.g005
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GAS2L3 (ATCC) and pCMV-SPORT6-GAS2L3-DM4, respec-
tively, with primers flanked by Fse1 (forward) and AscI (reverse) to
generate the pCS2-hGAS2L3 and pCS2-hGAS2L3-DM4 plas-
mids. To generate a non-degradable (D-box mutant) derivate of
human Cyclin B1, Arg 42 and Leu 45 were substituted with Gly
and Val, respectively, using QuikChange site-directed mutagen-
esis. The mutant gene was then cloned into pCS2 vector in-frame
with a 59 6xHis-tag. The vectors pEGFP-N1 and pCS2 were also
used. All plasmids were sequenced.
Tissue Culture, Cell Synchronization, and Transfection
HeLa, HeLa S3 (S3), and HEK293T (293) cells were
maintained in DMEM (Gibco) supplemented with 10% fetal
bovine serum (Gibco), penicillin, and streptomycin (Gibco) at
37uC, 5% CO2. For G1 extract preparation, S3 cells were grown
in suspension (1 L spinner flask, 85 rpm) until population reached
a density of approximately 5 610
5 cells/ml. The cells were then
incubated with 2 mM thymidine (Sigma-Aldrich) for 20–22 hrs,
washed and released into fresh media for 3–3.5 hrs, and blocked
again by incubating with 50 ng/ml nocodazole (Sigma-Aldrich)
for 12 hrs. Cells were then washed twice with fresh, warm media,
released for 3 hrs, and then harvested for generating G1 (APC/
C
Cdh1-active) extracts. Late-mitotic (APC/C
Cdc20-active) extracts
were prepared as follows: 293 cells were transiently transected
(using TransITH-293, Mirus Bio LLC) with His-tagged non-
degradable human Cyclin B1. Because transfection yields exceed-
ed 90% efficiency, nearly all cells were arrested in late mitosis
24 hrs post-transfection [31] and were therefore harvested directly
from the plate without any enrichment. Synchronization was
validated using FACSCalibur flow cytometer (BD) after propi-
dium-iodide staining of ethanol-fixed cells (Figure S5). We used
metafecteneH (Biontex) as the transfection reagent. MG132
(Sigma-Aldrich) was added at a final concentration of 20 mMt o
block proteasome activity. RO-3306 (ALEXIS Biochemicals) and
roscovitine (Sigma-Aldrich) were used at concentrations of
0.1 mM and 1 mM, respectively.
Extract Preparation and Degradation Assays
Extracts of S3 and 293 cells were prepared as follows:
synchronized cells were harvested, washed with PBS, lysed in
swelling buffer (20 mM HEPES, pH 7.7, 2 mM MgCl2,5m M
KCl, 1 mM DTT, EDTA-free protease inhibitor cocktail),
supplemented with energy-regeneration mix (1 mM ATP,
7.5 mM creatine phosphate, 70 mg/ml creatine phosphokinase,
0.1 mM EGTA), and homogenized by freeze–thawing and
passage through 20 G and 26 G needles successively. Extracts
were cleared by subsequent centrifugations (5 min at 2,7006g;
45 min at 18,0006g) and stored at 280uC.
Degradation assays were performed using 20 ml cell extracts
supplemented with 1 ml of 20X energy-regeneration mix, 1 mlo f
10 mg/ml Ubiquitin (Boston Biochem), 1 ml of 10 mg/ml
recombinant UbcH10 or UbcH10
DN,5mL of either 1 mg/ml
Emi1 C-terminus fragment, 3.5 mg/ml Securin, or PBS, and 1–
2 ml radiolabeled IVT product expressed in reticulocytes (Pro-
mega) with
35S-labeled methionine (PerkinElmer). Samples were
incubated at 30uC. Aliquots were taken every 20 or 40 min,
removed into sample buffer, and snap-frozen on dry ice. Samples
were resolved by SDS–PAGE and visualized by autoradiography.
To obtain interphase X. laevis egg extracts, eggs from HCG-
injected frogs were collected and washed in 1X MMR. Eggs were
dejellied with 2% cysteine, and activated by 1 mg/ml calcium
ionophore (Sigma-Aldrich), and then washed successively in XB
buffer and XB buffer with protease inhibitor mix (Roche), all at
18uC. Forty-five minutes post-activation, eggs were packed (1 min
at 1576g) in an Ultraclear centrifuge tube (Beckman Coulter, Inc.)
supplemented with cytochalasin B (Sigma-Aldrich), and crushed at
156806g for 10 min. The tube was pierced just above the yolk
pellet, and the cytoplasmic layer was collected by gravity for a
second clarifying spin (10 min at 156806g). The following
reagents were then added to final concentrations of 1X energy-
regeneration mix: 10 mg/ml cytochalasin B, 100 mg/ml cyclohex-
imide (Sigma-Aldrich), and 4% glycerol. Extracts were stored at
280uC. Protein degradations were assayed in interphase egg
extracts in the presence or absence of 1 nM recombinant Cdh1, or
in extracts that were driven into mitosis by preincubation with
10 mg/ml D90 cyclin B1 for 40 min at room temperature. In both
cases, 1 ml substrate was mixed with 15 ml extracts, 1 ml of 20X
energy-regeneration mix, and 1 ml of 10 mg/ml Ubiquitin.
Reactions were incubated at room temperature for a total of
2 hrs. Aliquots were taken every 30 min and processed, as
described (see reference [27] for more details).
Immunofluorescence and Microscopy
HeLa cells on coverslips (1.5) were fixed in 4% paraformalde-
hyde ([PFA] Sigma-Aldrich) for 20 min at room temperature
(RT), blocked with 20% fetal bovine serum with 0.1% Triton X-
100 in phosphate-buffered saline for 1 hr, and then incubated
overnight with primary antibodies at 4uC or, alternatively, for 20–
60 min at RT. After washing, coverslips were incubated with
secondary antibodies. The DNA was visualized with 5 mg/ml
DAPI (Sigma-Aldrich), and the coverslips were mounted on slides
with Immu-Mount mounting solution (Thermo Shandon Limited)
and sealed. Staining was analyzed using the AxioImager.Z1
upright and AxioObserver.M1 inverted fluorescence microscopes
(Carl Zeiss, Inc.) equipped with 100X oil immersion lens objectives
(NA 1.4). AxioVision Rel 4.8 (Carl Zeiss, Inc.) and ImageJ (NIH)
software were used for image processing.
Antibodies
The following primary antibodies were used for Western
blotting: rabbit polyclonal anti-hGas2l3 (serum, custom-made by
Covance), mouse monoclonal anti-aTubulin (DSHB, 12G10), and
mouse monoclonal anti-b Actin (DSHB, JLA20). HRP-conjugated
secondary antibodies were purchased from Jackson ImmunoR-
esearch Inc. The following primary antibodies were used for IF:
rabbit polyclonal anti-hGas2l3 (serum, custom-made by Covance),
mouse monoclonal and rabbit polyclonal anti-Aurora B (Abcam,
ab3609, ab2254), rabbit polyclonal MKLP1 (Gene Tex,
GTX30315), mouse monoclonal anti-aTubulin (Abcam,
ab7291), mouse monoclonal anti-FLAGH M2 (Sigma-Aldrich,
F3165), and mouse monoclonal anti-Myc (DSHB, 9E10).
Secondary antibodies used for IF include: Alexa Fluor 488-,
594-, 647-labeled donkey, anti-mouse, rabbit, or goat (Molecular
Probes), A11029, A11008, A21201, A31571, A31573, and
A21447), and Alexa Fluor 555-labeled goat anti-rabbit (Molecular
Probes, A21429).
Supporting Information
Figure S1 Anti-hGas2l3 rabbit serum detects Gas2l3-
EGFP at the constriction sites. (A) HeLa cells were
transfected with Gas2l3-EGFP and fixed with 4% PFA after
32 hrs. The fixed cells were immunolabeled with anti-hGas2l3
rabbit serum and Alexa Fluor 555 goat anti-rabbit secondary
antibodies (Invitrogen). For imaging, we used the AxioImager.Z1
upright fluorescence microscope (Carl Zeiss, Inc.) equipped with
100X oil DIC immersion lens objectives (NA 1.4). (B) Fluorescence
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quantified by linescan (ImageJ).
(PDF)
Figure S2 siRNA experiments confirm Gas2l3 localiza-
tion at the constriction sites and the specificity of anti-
hGas2l3 serum. (A) Real-time qPCR analysis of hGAS2L3
expression (relative quantification [RQ], normalized to hHPRT1
mRNA levels [in triplicates]) in HeLa cells treated with either
hGAS2L3 siRNA (Sigma-Aldrich; EHU130291 Hs01
00152121_AS) or scrambled siRNA ([siControl] Sigma-Aldrich;
SIC001). We used DharmaFECT (Thermo Scientific, D-001630-
02), as transfection reagent, following the manufacturer’s protocol.
Cells were harvested for RNA extraction 40 h post-transfection.
Primers used for real-time qPCR: HPRT1-RT-F: CGTGAT-
TAGTGATGATGAACCAG; HPRT1-RT-R: CGAGCAA-
GACGTTCAGTCCT; hGAS2L3-RT-F: GCTGTCGGCAT-
GAAGAGC; hGAS2L3-RT-R: AATCGATGAGAACAA
CTACAAGGA. (B) HeLa cells were cotransfected (Dharma-
FECT) with Gas2l3-EGFP or empty pCS2 vector (-), and with
either a negative control (siControl) or GAS2L3 siRNAs. Forty hrs
post-transfection, cells were harvested for Western blot analysis
with anti-GFP (Santa Cruz) and anti-Actin ([loading control],
Sigma-Aldrich, A3853). (C) HeLa cells were cotransfected with
Gas2l3DM4-EGFP and with either a negative control (siControl)
or GAS2L3 siRNAs. We used DharmaFECT as a transfection
reagent. Transfection mix included siGLO to detect siRNA
positive cells. Thirty-six hrs post-transfection, cells were fixed (4%
PFA), stained with DAPI, and imaged (100X DIC oil lens). White
arrows indicate Gas2l3 at the constriction sites. (D) HeLa cells
were transfected (DharmaFECT) with either hGAS2L3 siRNA or
scrambled siRNA (siControl). Transfection mix included siGLO
red transfection indicator to detect siRNA positive cells. Thirty-six
hrs post-transfection, cells were fixed (4% PFA), immunolabeled
with anti-hGas2l3 rabbit serum and Alexa Fluor 555 goat anti-
rabbit secondary antibodies (Invitrogen), and stained with DAPI.
For imaging, we used the AxioImager.Z1 upright fluorescence
microscope (Carl Zeiss, Inc.) equipped with 100X oil DIC
immersion lens objectives (NA 1.4).
(PDF)
Figure S3 The localization of Gas2l3 at the constriction
sites is unaffected by the D-box. HeLa cells were transfected
with EGFP-Gas2l3 (A) or the D-box–mutant derivate of Gas2l3-
EGFP (Gas2l3-DM4-EGFP) (B). Cells were fixed (4% PFA) 32 hrs
post-transfection and immunolabeled with anti-Aurora B antibod-
ies (Abcam, ab2254) and Alexa Fluor 555 goat anti-rabbit
secondary antibodies (Invitrogen). For imaging, we used the
AxioImager.Z1 upright fluorescence microscope (Carl Zeiss, Inc.)
equipped with 100X oil immersion lens objectives (NA 1.4).
(PDF)
Figure S4 Gas2l3 mobility in SDS-PAGE is hardly
shifted by mitotic phosphorylation. Radiolabeled Gas2l3
IVT product was incubated in 293 late mitotic cell extracts (see
main text) for 15 min in the presence (+) of the Cdk1 inhibitor
RO-3360 or with DMSO ([-] control). In addition, after 15 min of
incubation, extracts supplemented with either RO-3360 or
DMSO were mixed (+/2). Samples were assayed by SDS-PAGE
and autoradiography. Radiolabeled EGFP-Gas2l3 is being used as
a 104 kDa marker, 29 kDa higher than the calculated Gas2l3
molecular weight (MW) of 75 kDa.
(PDF)
Figure S5 HEK293 cells expressing non-degradable full-
length Cyclin B1 arrest in mitosis. HEK293 cells were
transfected with non-degradable full-length Cyclin B1 (ndCycB1).
Thirty hrs post-transfection, cells were harvested for FACS
analysis of their DNA content (PI staining). In addition,
asynchronous (US) and nocodazole-arrested (Noc) 293 cells were
harvested for FACS analysis. All samples were fixed (70% EtOH),
stained with PI, and assayed using FACSCalibur (BD) and ModFit
LT
TM software.
(PDF)
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